Skip to main content
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriasis
1
1
Plaque Psoriasis
0
0.99
Receptors
0
0.58
Biologic Therapy
0
0.29
Interleukin
0
0.98
Skin Lesion
0
0.25
Dermatitis
0
0.14
Cosmetic Dermatology
0
0.1
COVID-19
0
0.1
Atopic Dermatitis
0
0.08
Clinical Research
0
0.08
Colitis
0
0.08
Cosmetics
0
0.08
Cytokines
0
0.08
Dermatoses
0
0.08
Face
0
0.08
Hospital
0
0.08
Nasopharyngitis
0
0.08
Pathogenesis
0
0.08
Phototherapy
0
0.08
Severity Index
0
0.08
Stomach
0
0.08
Suicide
0
0.08
Tyrosine Kinase
0
0.08
Ulcerative Colitis
0
0.07
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Rheumatology
0
0.7
Edit Tags